HRT :: Wyeth loses second hormone therapy drug case
Philadelphia Jury returns verdict that Wyeth’s hormone replacement therapy caused breast cancer and awards $3 million to Ohio woman and her husband.
HRT
HRT :: Wyeth plans to appeal in Philadelphia Prempro hormone therapy trial
Wyeth (NYSE: WYE) announced today that the jury in the case of Jennie Nelson v. Wyeth, in the Philadelphia Court of Common Pleas, found in favor of the plaintiffs and awarded damages of $3 million. Wyeth plans to appeal.
Heart Risk :: Guidelines on Women’s Lifetime Heart Risk
Health care professionals should focus on women’s lifetime heart disease risk, not just short-term risk, according to updated American Heart Association guidelines.
HRT :: HRT less likely to develop diabetes
The North American Menopause Society in a revised position statement said that women taking hormone replacement therapy appear to be less likely to develop the diabetes disease.
HRT :: Wyeth to pay $1.5 million in hrt Prempro trial
US Philadelphia jury found Wyeth’s hormone replacement therapy (HRT) Prempro was responsible for an Arkansas woman’s breast cancer and ordered the U.S. drugmaker Wyeth to pay $1.5 million in compensatory damages.
Breast Cancer :: Breast cancer drop linked to decline in HRT
In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at The University of Texas M. D. Anderson Cancer Center.
Hearing Loss :: Hormone therapy tied to hearing loss in older women
The hormone progestin, as a component of hormone replacement therapy (HRT) following menopause, appears to exacerbate deficits in hearing sensitivity and auditory speech processing, according to a research team at the Rochester School of Medicine and Dentistry in New York.
Osteoporosis :: Side Effects May Sideline Estrens Osteoporosis Drugs
Estrens did build bone, but might also raise cancer risks, study finds. Experimental osteoporosis drugs called estrens do not perform as well as researchers had hoped, new animal studies suggest.
Trichotillomania :: Approach best for hair-pulling disorder – tricholomania
A new study suggests that behavioral therapy plus medication is the most effective approach to treating trichotillomania, a psychiatric disorder characterized by obsessive hair pulling.
Lung Cancer :: Hormone replacement therapy and decreased survival in women
According to a recent article published in the Journal of Clinical Oncology, women with lung cancer who have taken hormone replacement therapy (HRT) may have a significantly poorer overall survival than those who have never taken HRT.